News

UiPath Stock: Taking Advantage Of Gen AI (NYSE:PATH)

6 Mins read

Trading at around $15.4 with a market cap of $8.7 billion, UiPath (NYSE:PATH) is rated as Buy to Strong Buy by analysts as pictured below. This is based on strong grades for Growth, Profitability, Momentum, and EPS revision which during therevised

Read the full article here

Related posts
News

HTD: Tax-Advantaged Monthly Income From Dividends (NYSE:HTD)

1 Mins read
This article was written by Follow David A. Johnson is founder and principal of Endurance Capital Management, a New Jersey Limited Liability…
News

Jasper Therapeutics, Inc. (JSPR) Discusses Investigation Into BEACON Study Anomalies and Preliminary ETESIAN Asthma Data - Slideshow (NASDAQ:JSPR) 2025-12-04

1 Mins read
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We…
News

Qiagen N.V. (QGEN) Presents at Evercore 8th Annual Healthcare Conference Transcript

1 Mins read
Follow Play Earnings CallPlay Earnings Call Qiagen N.V. (QGEN) Evercore 8th Annual Healthcare Conference December 3, 2025 10:50 AM EST Company Participants…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *